Cadrenal Therapeutics Inc (CVKD)

Nov 20, 2024

CVKD: Recent Financings Raise $9.8 Million… - MSN

Nov 20, 2024

Nov 19, 2024

Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook - StockTitan

Nov 19, 2024

Nov 18, 2024

(CVKD) Technical Data - Stock Traders Daily

Nov 18, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Cadrenal Therapeuti - GuruFocus.com

Nov 15, 2024

Nov 12, 2024

Cadrenal's Tecarfarin Shows Promise for LVAD Patients in Key Medical Congress Data | CVKD Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS - PR Newswire

Nov 12, 2024

Nov 11, 2024

Cadrenal shares gain; analyst highlights Buy rating and key LVAD trial advancements - Investing.com Canada

Nov 11, 2024

Nov 09, 2024

Cadrenal Therapeutics Provides Third-Quarter Corporate Update - Defense World

Nov 09, 2024

Nov 08, 2024

Cadrenal Therapeutics Advances Tecarfarin Development - TipRanks

Nov 08, 2024

Nov 08, 2024

(CVKD) Long Term Investment Analysis - Stock Traders Daily

Nov 08, 2024

Nov 07, 2024

Cadrenal Therapeutics Raises $9.8M, Advances Unique Anticoagulant Drug Development | CVKD Stock News - StockTitan

Nov 07, 2024

Nov 07, 2024

CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATE - PR Newswire

Nov 07, 2024

Nov 01, 2024

Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds - StockTitan

Nov 01, 2024

Oct 31, 2024

Here's Why We're Watching Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn Situation - Simply Wall St

Oct 31, 2024

Oct 28, 2024

We're Keeping An Eye On Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn Rate - Yahoo Finance

Oct 28, 2024

Oct 28, 2024

(CVKD) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Oct 28, 2024

Oct 24, 2024

Cadrenal Therapeutics secures $5.1 million in share sale - Investing.com

Oct 24, 2024

Oct 24, 2024

Cadrenal Therapeutics Raises $5.1 Million for Tecarfarin - TipRanks

Oct 24, 2024

Oct 24, 2024

Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility - PR Newswire

Oct 24, 2024

Oct 23, 2024

CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUM - PR Newswire

Oct 23, 2024

Oct 17, 2024

Short Interest in Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) Drops By 7.2% - MarketBeat

Oct 17, 2024

Oct 15, 2024

Renaissance Technologies LLC Reduces Stock Position in Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) - MarketBeat

Oct 15, 2024

Oct 07, 2024

Long Term Trading Analysis for (CVKD) - Stock Traders Daily

Oct 07, 2024

Oct 03, 2024

Jacksonville stocks rise as market hits record highs - Jacksonville Daily Record

Oct 03, 2024

Sep 30, 2024

Short Interest in Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) Rises By 22.8% - MarketBeat

Sep 30, 2024

Sep 30, 2024

Cadrenal Therapeutics Inc (CVKD-Q) QuotePress Release - The Globe and Mail

Sep 30, 2024

Sep 26, 2024

Where are the Opportunities in (CVKD) - Stock Traders Daily

Sep 26, 2024

Sep 25, 2024

Cadrenal Therapeutics Unveils Phase 3 Trials and Market Strategy - TipRanks

Sep 25, 2024

Sep 23, 2024

Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference - Kilgore News Herald

Sep 23, 2024

Sep 19, 2024

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) Forecasted to Earn Q3 2024 Earnings of ($2.18) Per Share - MarketBeat

Sep 19, 2024

Sep 18, 2024

Applied Therapeutics (NASDAQ:APLT) Trading Down 4.1% - Defense World

Sep 18, 2024

Sep 18, 2024

WATCH LIVE: Fed Chair Jerome Powell speaks after a 50bp interest rate cut - Investing.com

Sep 18, 2024

Sep 16, 2024

Cancer Biotech Nuvalent’s Stock Jumps on Positive Data - MSN

Sep 16, 2024

Sep 16, 2024

Cadrenal Therapeutics (CVKD) Stock Rallies In After-Market Trading Ahead Of Regulatory Meeting - Stocks Telegraph

Sep 16, 2024

Sep 12, 2024

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) Short Interest Update - MarketBeat

Sep 12, 2024

Sep 12, 2024

Eli Lilly invests $1.8B to boost manufacturing footprint in Ireland - MSN

Sep 12, 2024

Sep 11, 2024

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing - Yahoo Finance

Sep 11, 2024

Sep 05, 2024

Cadrenal Therapeutics regains Nasdaq compliance - Investing.com India

Sep 05, 2024

Aug 23, 2024

Cadrenal gears up for FDA talks on heart drug trial - Investing.com India

Aug 23, 2024

Aug 22, 2024

Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients - PR Newswire

Aug 22, 2024

Aug 20, 2024

Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients - PR Newswire

Aug 20, 2024

Aug 19, 2024

Upcoming Stock Splits This Week (August 19 to August 23) – Stay InvestingTHE BHARAT EXPRESS NEWS - The Bharat Express News

Aug 19, 2024

Aug 19, 2024

Upcoming Stock Splits This Week (August 19 to August 23) – Stay Invested - MSN

Aug 19, 2024

Aug 16, 2024

Cadrenal Therapeutics to Implement 1-for-15 Reverse Stock Split - Marketscreener.com

Aug 16, 2024

Aug 16, 2024

Cadrenal announces 1-for-15 reverse stock split By Investing.com - Investing.com Australia

Aug 16, 2024

Aug 16, 2024

Cadrenal announces 1-for-15 reverse stock split - Investing.com

Aug 16, 2024

Aug 15, 2024

Cadrenal Therapeutics Inc: Analyzing CVKD Stock Trends - The InvestChronicle

Aug 15, 2024

Aug 14, 2024

CVKDCadrenal Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Aug 14, 2024

Aug 14, 2024

Cadrenal Therapeutics to Present at Upcoming Investor Conferences - Longview News-Journal

Aug 14, 2024

Aug 12, 2024

Cadrenal Therapeutics, Inc. (CVKD): A New Penny Stock to Buy Now - Yahoo Finance

Aug 12, 2024

Aug 12, 2024

Q3 2024 Earnings Estimate for Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) Issued By HC Wainwright - Defense World

Aug 12, 2024